PIM
ALDR

Partner Investment Management’s Alder Biopharmaceuticals ALDR Stock Holding History

Partner Investment Management’s Portfolio ALDR Stock Details ALDR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-17,247
Closed -$235K – 105
2019
Q1 		$235K Buy
+17,247
New +$223K 0.27% 69
2018
Q4 		– Sell
-15,886
Closed -$265K – 128
2018
Q3 		$265K Sell
15,886
-7,910
-33% -$143K 0.2% 92
2018
Q2 		$376K Sell
23,796
-5,983
-20% -$90.9K 0.3% 88
2018
Q1 		$378K Buy
+29,779
New +$431K 0.41% 65
2017
Q3 		– Sell
-15,296
Closed -$175K – 102
2017
Q2 		$175K Sell
15,296
-6,509
-30% -$120K 0.24% 78
2017
Q1 		$454K Sell
21,805
-41,766
-66% -$925K 0.55% 63
2016
Q4 		$1.32M Buy
63,571
+21,611
+52% +$562K 1.75% 20
2016
Q3 		$1.38M Sell
41,960
-33,042
-44% -$1.01M 2.04% 14
2016
Q2 		$1.87M Buy
75,002
+5,260
+8% +$142K 3.06% 5
2016
Q1 		$1.71M Buy
69,742
+32,986
+90% +$764K 2.78% 11
2015
Q4 		$1.21M Buy
36,756
+13,831
+60% +$468K 1.99% 18
2015
Q3 		$751K Buy
22,925
+4,792
+26% +$204K 1.14% 31
2015
Q2 		$961K Buy
18,133
+2,742
+18% +$99.7K 1.35% 29
2015
Q1 		$444K Buy
15,391
+7,969
+107% +$219K 0.67% 59
2014
Q4 		$216K Sell
7,422
-16,238
-69% -$291K 0.09% 75
2014
Q3 		$300K Sell
23,660
-4,233
-15% -$64K 0.11% 48
2014
Q2 		$560K Buy
+27,893
New +$393K 0.11% 56

Other funds holding ALDR

Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
SC
Samlyn Capital New York $6.14B AUM 42.05% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Partner Investment Management's ALDR Position: Q2 2019 in Review

Partner Investment Management sold out of Alder Biopharmaceuticals (ALDR) in Q2 2019, closing a stake of 17,247 shares — an estimated $235K sold.

Partner Investment Management first reported a position in ALDR in Q2 2014 and held it in 17 quarters. The position peaked at $1.87M in Q2 2016. 127 funds tracked by Wall St. Rank hold ALDR as of Q2 2019.

  • Partner Investment Management reported no remaining Alder Biopharmaceuticals position as of Q2 2019 after selling out during the quarter.
  • Partner Investment Management sold 17,247 Alder Biopharmaceuticals shares in Q2 2019, an estimated $235K.
  • Partner Investment Management first reported a position in Alder Biopharmaceuticals in Q2 2014 and held it in 17 quarters.
  • Partner Investment Management's Alder Biopharmaceuticals position peaked at $1.87M in Q2 2016.
  • 127 funds tracked by Wall St. Rank held Alder Biopharmaceuticals as of Q2 2019.

Based on Partner Investment Management's 13F filing for Q2 2019, filed 14 Aug 2019.